Growing healthcare awareness and changing lifestyles are key factors that fuel the global Gynecological Devices Market. The industry is poised to surpass USD 21 billion by the end of the forecast period (2016 to 2024). Rising income levels in developing countries, such as Indonesia, Vietnam, and India may significantly contribute to industry demand in the years to come. High incidence of gynecological anomalies, like menorrhagia, uterine fibroids, and cervical cancer could positively influence global demand.
Gynecological devices are an integral part of the medical devices industry. Adoption of specialized gynecological procedures in hospitals and in healthcare centers fuels the need for such devices. Introduction of sophisticated imaging devices, such as 3D endoscopes holds promise for further market progress. High incidence of diseases, such as uterine fibroids and sexually transmitted diseases can propel demand in the years to come. Browse Details of Report @ https://www.hexaresearch.com/research-report/gynecological-device-market The global gynecological devices market is segmented as per products and regions. On the basis of products, the industry is trifurcated into surgical devices, hand instruments, and diagnostic imaging systems. Hand instruments are further segmented into biopsy forceps, vaginal speculum, trocars, tenaculum, curettes, and others. Surgical devices comprise gynecological endoscopy devices, endometrial ablation devices, fluid management systems, and female contraceptive/sterilization devices. Surgical devices hold the highest share in the overall Gynecological Devices Market because of growing demand for female contraceptives & endoscopy devices. Use of endoscopes in gynecology is gradually increasing. Some of their key applications in gynecology are resectoscopes, endoscopic imaging, hysteroscopes, and laparoscopes. Being minimally invasive, procedures, such as hysterectomy, hysterotomy, and laparoscopy may favorably impact demand for endoscopes in the near future. Awareness about the importance of early detection of gynecological disorders and use of lighting in diagnostics solutions could play a key role in fuelling industry growth in the years to come. Geographically, the gynecological devices industry is segmented into Latin America, Europe, North America, Asia Pacific, and the Middle East & Africa. North America generates the highest revenues in the overall industry. High concentration of market competitors and widespread adoption of advanced technologies are key regional drivers. Healthcare centers in the region carry out routine check-ups for women to rule out the possibilities of cervical & breast cancers. Asia Pacific can witness robust growth over the forecast period. Factors that fuel this region are medical tourism and affordable treatment costs. Most manufacturing facilities are increasingly being established in India & China. Reasons that support such a trend are cheap labor costs, availability of skilled healthcare professionals, and advanced manufacturing facilities. This has also lead to low manufacturing costs of medical devices. Key companies operating in the global gynecological devices market are Medtronic plc; Stryker Corporation; Cooper Surgical Inc.; Boston Scientific Corporation; and Richard Wolf Gmbh among many others. In September 2016, Aqueduct Medical received FDA (Food and Drug Administration) approval for a device that creates cervical dilation within a few minutes. Aqueduct Medical is an Israel based startup dealing in medical devices. The process is carried out without general anesthesia. At present, the company is conducting clinical trials in Europe. The product would soon be available in Israel once it is approved by the Health Ministry. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry
0 Comments
The worldwide global Blood Gas and Electrolyte Analyzers Market size is anticipated to reach nearly USD 715 million by 2024. Rise in diseases such as cancer, obesity, diabetes, and respiratory disorders can drive the market during the forecast period (2016 to 2024). These devices help in the diagnosis of diseases, such as chronic obstructive pulmonary disease (COPD), drug overdose, and asthma among others. Demand for portable devices, introduction of newer technologies, and rising healthcare expenditure can impel the industry. Moreover, multi-parameter monitoring devices could favor industry growth.
Increasing geriatric population will also propel market growth. As per the World Health Organization (WHO), the population belonging to the age group of 65 years & above may rise to 16% by 2050 from 7% in 2000. This in turn can increase the demand for point-of-care diagnostic testing which can positively impact the global market in the long run. Lack of trained professionals is a major restraint in the global industry. Additionally, unfavorable reimbursement scenarios and complexities in the interpretation of test results are the other market challenges. Browse Details of Report @ https://www.hexaresearch.com/research-report/blood-gas-electrolyte-analyzers-market The blood gas and electrolyte analyzers market is fragmented into products, applications, end-users, and geographies. On the basis of applications, the industry is segmented into electrolyte analyzers and combined analyzers . Combined analyzers may continue dominating the overall market in the forecast period. This segment is projected to grow at a CAGR nearly 5.5%. They provide results for both electrolyte & blood count in samples of blood, serum, creatinine, and dialysate or plasma. Also, these devices can analyze urine, nitrogen, and electrolytes in a single test sample. Based on products, the blood gas and electrolyte analyzers market is bifurcated into portable analyzers and benchtop analyzers. The segment of portable analyzers can continue leading the industry during the forecast period. Surging demand for automated, portable, low maintenance, and self-monitoring devices may fuel demand till 2024. Portable devices are best suited for mobile & bedside monitoring. The various end users are hospitals, Point-of-care (POC), clinical laboratories, and diagnostic centers. POC devices are widely popular in critical care departments, cardiothoracic surgical departments, and in emergency transport systems. These devices entail automated sample handling, render users variability, and help minimize errors. Thus, they are estimated to be high on consumer preference. As per geographies, the market is divided into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa (MEA). North America dominated the overall industry in 2014. Increasing patients in ICUs, hospitals, and in emergency wards can favorably influence the market. It is anticipated that Latin America will expand at a 5.5% CAGR from 2016 to 2024. Asia Pacific can register a CAGR more than 6.6% over the next eight years. The region is driven by high disposable incomes in countries, like India and China. Government initiatives can also support the market during the forecast period. Rising cases of diabetes, hypertension, and cancer are contributing to greater healthcare awareness & improvements in healthcare infrastructure in Asia Pacific. This could benefit the market significantly. Key players operating in the global blood gas and electrolyte analyzers market are Abbott Laboratories, Erba Mannheim, Roche Diagnostics, and Siemens Healthcare. Companies resort to strategic business ventures and expansion of product portfolio for better market penetration. In September 2012, Germany based diagnostic devices producer, Erba Mannheim acquired Maxmat S.A., a French company that operated in the area of medical laboratory devices. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-report/blood-gas-electrolyte-analyzers-market The global Tissue Engineering Market stood at USD 5.5 billion in 2015 and is expected to witness considerable growth even over the forecast period (from 2016 to 2024). Growing needs to bridge the gap between organ demand & supply are expected to drive the industry demand in the near future. Growing popularity in a variety of sectors including urological products, neurology, burn treatment etc. is also anticipated to boost the market growth. Organs developed using this method have high efficiency and durability. Rising applications of this method from surgical treatment of tissues and prosthetics to liver, corneal, cardiac tissue engineering is said to propel the growth from 2016 to 2024. The global market is categorized as applications and regions.
The applications include GI & gynecology, cancer, cord blood & cell banking, skin or integumentary, urology, dental, musculoskeletal, spine, orthopedics, neurology, and cardiology & vascular. The orthopedic application sector occupied more than half of the total market share in 2015. The sector is further expected to continue leading the market on account of the increased number of bone implants due to accidents as well as a geriatric population base. The neurology sector is one of the fastest-growing application sectors since it has the wider scope for development. In addition to this, a significant amount of research in the neurology sector is also anticipated to drive the sector growth. Browse Details of Report @ https://www.hexaresearch.com/research-report/tissue-engineering-market Regionally, North America dominated the global tissue engineering market in 2015 accounting for the largest share. It is further projected to continue its dominance even during the forecast period. This can be attributed to the presence of leading players in the region and high financial support for R&D from the government as well as some private organizations. The Asia-Pacific region is expected to be the most lucrative region in the near future. This is mainly because of the existence of immense manpower and highly developed procedures coupled with government funding. The European market is said to register reasonable growth prospects due to the presence of stringent regulatory rules. nd working in partnerships with small-scale companies so as to influence technology & research advancements and to expand the product portfolio. Some of the key players include Sanofi S. A.; CryoLife Inc.; StemCells Inc.; and BioMimetic Therapeutics Inc. Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry |
Archives
October 2023
|